BBVA USA Bancshares’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $2.31M | Sell |
12,375
-783
| -6% | -$153K | 0.11% | 180 |
|
|
2020
Q4 | $2.22M | Buy |
13,158
+333
| +3% | +$49.7K | 0.11% | 169 |
|
|
2020
Q3 | $2.04M | Sell |
12,825
-692
| -5% | -$107K | 0.12% | 163 |
|
|
2020
Q2 | $2.22M | Sell |
13,517
-572
| -4% | -$87.8K | 0.13% | 149 |
|
|
2020
Q1 | $1.96M | Sell |
14,089
-1,708
| -11% | -$235K | 0.14% | 148 |
|
|
2019
Q4 | $2.08M | Sell |
15,797
-4,296
| -21% | -$498K | 0.12% | 166 |
|
|
2019
Q3 | $2.25M | Sell |
20,093
-2,311
| -10% | -$257K | 0.14% | 151 |
|
|
2019
Q2 | $2.48M | Buy |
22,404
+2,134
| +11% | +$251K | 0.15% | 144 |
|
|
2019
Q1 | $2.63M | Buy |
20,270
+2,831
| +16% | +$344K | 0.17% | 138 |
|
|
2018
Q4 | $2.02M | Buy |
17,439
+8,090
| +87% | +$904K | 0.14% | 146 |
|
|
2018
Q3 | $1M | Buy |
9,349
+474
| +5% | +$47.4K | 0.06% | 265 |
|
|
2018
Q2 | $757K | Sell |
8,875
-6
| -0.1% | -$493 | 0.05% | 295 |
|
|
2018
Q1 | $686K | Sell |
8,881
-194
| -2% | -$15.6K | 0.04% | 317 |
|
|
2017
Q4 | $767K | Buy |
9,075
+1,289
| +17% | +$110K | 0.05% | 312 |
|
|
2017
Q3 | $666K | Buy |
7,786
+18
| +0.2% | +$1.48K | 0.04% | 326 |
|
|
2017
Q2 | $640K | Sell |
7,768
-2
| -0% | -$163 | 0.04% | 331 |
|
|
2017
Q1 | $653K | Buy |
7,770
+1,636
| +27% | +$131K | 0.04% | 328 |
|
|
2016
Q4 | $451K | Buy |
6,134
+1,755
| +40% | +$131K | 0.03% | 379 |
|
|
2016
Q3 | $351K | Buy |
4,379
+513
| +13% | +$41.1K | 0.03% | 422 |
|
|
2016
Q2 | $304K | Sell |
3,866
-162
| -4% | -$12.2K | 0.02% | 431 |
|
|
2016
Q1 | $290K | Sell |
4,028
-81
| -2% | -$6.13K | 0.02% | 437 |
|
|
2015
Q4 | $346K | Sell |
4,109
-333
| -7% | -$27.6K | 0.03% | 385 |
|
|
2015
Q3 | $372K | Sell |
4,442
-102,559
| -96% | -$8.66M | 0.03% | 359 |
|
|
2015
Q2 | $8.93M | Sell |
107,001
-1,398
| -1% | -$107K | 0.5% | 57 |
|
|
2015
Q1 | $7.88M | Sell |
108,399
-2,310
| -2% | -$164K | 0.35% | 92 |
|
|
2014
Q4 | $7.64M | Buy |
110,709
+105,203
| +1,911% | +$7.1M | 0.35% | 95 |
|
|
2014
Q3 | $357K | Sell |
5,506
-216,133
| -98% | -$13.7M | 0.02% | 443 |
|
|
2014
Q2 | $13.8M | Sell |
221,639
-3,538
| -2% | -$211K | 0.6% | 43 |
|
|
2014
Q1 | $13.3M | Sell |
225,177
-4,248
| -2% | -$237K | 0.6% | 42 |
|
|
2013
Q4 | $11.7M | Buy |
229,425
+3,812
| +2% | +$191K | 0.51% | 55 |
|
|
2013
Q3 | $11.4M | Buy |
225,613
+4,952
| +2% | +$259K | 0.54% | 54 |
|
|
2013
Q2 | $10.8M | Buy |
+220,661
| New | +$12M | 0.55% | 53 |
|
Other funds holding LLY
BBVA USA Bancshares's LLY Position: Q1 2021 in Review
BBVA USA Bancshares reduced its Eli Lilly (LLY) stake by 6% in Q1 2021, selling an estimated $153K and leaving 12,375 shares worth $2.31M. The position accounts for 0.11% of the portfolio, ranked #180.
BBVA USA Bancshares first reported a position in LLY in Q2 2013 and has held it in 32 quarters since. The position peaked at $13.8M in Q2 2014. 1,949 funds tracked by Wall St. Rank hold LLY as of Q1 2021.
- BBVA USA Bancshares held 12,375 shares of Eli Lilly worth $2.31M as of Q1 2021.
- BBVA USA Bancshares sold 783 Eli Lilly shares in Q1 2021, an estimated $153K.
- Eli Lilly made up 0.11% of BBVA USA Bancshares's portfolio in Q1 2021, its #180 holding.
- BBVA USA Bancshares first reported a position in Eli Lilly in Q2 2013 and has held it in 32 quarters since.
- BBVA USA Bancshares's Eli Lilly position peaked at $13.8M in Q2 2014.
- 1,949 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2021.
Based on BBVA USA Bancshares's 13F filing for Q1 2021, filed 23 Apr 2021.